ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RGS Regenersis

229.00
0.00 (0.00%)
28 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Regenersis LSE:RGS London Ordinary Share GB00B06GNN57 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 229.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Regenersis Share Discussion Threads

Showing 1601 to 1623 of 2000 messages
Chat Pages: Latest  68  67  66  65  64  63  62  61  60  59  58  57  Older
DateSubjectAuthorDiscuss
15/1/2015
15:54
Tms8, because he bought more than 2 months before the announcement of the results (on 17th March).

The rule is that he can't buy between the period end and the results, but if the gap to the results is longer than 2 months then he can't buy during that 2 months but can buy before then.

Hope that's clear! That's my understanding for year ends anyway, so I assume it also applies to interim periods.

rivaldo
15/1/2015
14:31
Blin's a director. How come he can buy shares in a closed period?
tms8
15/1/2015
14:18
No, I think the bottom is in, which is why I've bought this am.. two lots. Small holding but.
brucie5
15/1/2015
10:39
I would be surprised to see 200 again, though anything is possible; such as the Swiss franc falling 40% in a flash crash this morning.
cestnous
15/1/2015
10:34
Frank Blin takes a maiden stake. 18000 shares not to be entirely sniffed at. I'm seeing a bottom at 200 now, with the share price snagged into a recovering 100wma. Target has to be a recovery of £3.40 level, which is good enough for me.
brucie5
14/1/2015
19:08
Gargleblaster, last update was not too bad either, but still share price plunged.
macarre
14/1/2015
15:19
14 Jan 2015 Regenersis PLC RGS Panmure Gordon Buy 228.25 was 247.00 target 403.00 403.00 Reiterates
stardrops2
14/1/2015
12:41
Technical correction (MA100) + FTSE down quite a bit. If it does not rebound today, likely to do so @ 223p. Upward trend should resume soon, imo. I'll watch for a likely top up.
macarre
14/1/2015
11:51
Completely agree with you there Riv.
cestnous
14/1/2015
11:26
Panmure say Buy with a 403p target (compared to ED's of 500p):



Poor markets today combined with small fry profit-takers from the run-up have combined this morning with RGS' usual volatility. No reason at all imo why it shouldn't continue its recent recovery given the low rating - and at this level even the 2% dividend yield is an attraction.

rivaldo
14/1/2015
09:08
It could be a good time to buy/top up if 230p holds. If it fails then bets off for now...
essential
14/1/2015
09:06
Eq. Dev today;


Regenersis provides a suite of product life cycle support services designed to help companies and their customers successfully deploy, protect, sustain, retire and re-use digital technology. It is also the global #1 for 'data erasure' software to protect individuals/corporates from ID/data theft and cyber-crime.

This morning the Board confirmed that H1'15 results for the 6 months to 31 December 2014 would be "in line with expectations". For FY15 we are forecasting turnover, adjusted PBT and EPS of £229m (+15.9%), £16.1m (+55%) and 18.0p (+11.6%) respectively.

Looking further ahead, we reckon adjusted EPS could climb at a 20% CAGR between 2016-20, driven by margin expansion and revenue growth of 8-9% pa - split ''Depot Solutions'' (+5%) and "Software and Advanced Solutions " (+15%).

On valuation, we reiterate our 500p/share target price (twice current levels) where we estimate the 'Software and Advanced Solutions' division represents 75% of the total enterprise value.

Download full report here


Free to download full report on registering. This is commissioned research

cestnous
14/1/2015
08:45
Market seems to be interpreting the lack of info with suspicion.
gargleblaster
14/1/2015
08:38
Agree AdamB, if you compare with. Jan 2014 Also the way I read it the benefits from Blannco will not flow through til H2, not sure if that is what the mkt is expecting ?


Locked in a profit for now... probably the wrong decision....but will look to revisit on any weakness

GLA

jakedog2
14/1/2015
08:16
THats quite an un-RGS-like announcement - they usually give more commmentary about whats going on. Reassuring that they're on course for market expectations, though a number or two would have been nice!
adamb1978
14/1/2015
08:15
Apart from the bland RNS with no guidance on achieving/exceeding expectations the chart actually looks quite strong...
essential
14/1/2015
08:06
New investor note from Equity Development

hxxp://www.equitydevelopment.co.uk/doc/1304.pdf

brummy_git
14/1/2015
07:46
Should justify share price here
nw99
14/1/2015
07:36
Excellent news - given the amount of profit warnings around, trading nicely in line is perfectly good, and given where the share price is now against prior levels there's plenty of upside.

With even better contributions from Blancco and Digital Care in H2 we can look forward with confidence.

rivaldo
14/1/2015
07:23
Not an exciting, but still reassuring update this morning. They seem confident about second half trading, and so am I.
macarre
13/1/2015
21:06
rivaldo ,

Ha ha

jakedog2
13/1/2015
19:34
so its trading update tomorrow anyone want to chuck some numbers around
stardrops2
13/1/2015
10:32
Now amended - cheers Mick, too many companies beginning with the letter R :o))
rivaldo
Chat Pages: Latest  68  67  66  65  64  63  62  61  60  59  58  57  Older

Your Recent History

Delayed Upgrade Clock